Mylan And Biocon Launch Fulphila In Canada

Biosimilar Pegfilgrastim Rival To Neulasta Joins Apotex’ Lapelga Version

 
• By David Wallace
  
Canada_Victory_Sign
Mylan and Biocon’s Fulphila is the second biosimilar pegfilgrastim in Canada • Source: Shutterstock

More from Products

More from Generics Bulletin